Ads
related to: merck
Search results
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive via Yahoo Finance· 23 hours agoDive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical part of viral vector-based gene therapy...
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Pharmaceutical Technology via Yahoo Finance· 22 hours agoMerck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive...
Billionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You?
Motley Fool via Yahoo Finance· 60 minutes agoDespite this solid rebound, Bank of America appears to be attractively valued. Its shares trade at a...
Healthcare data company Atropos Health receives $33m in Series B funding round
Hospital Management via Yahoo Finance· 22 minutes agoThe funding round involved participation from both new and existing investors, including McKesson...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 4 days agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Institutions' substantial holdings in Merck implies that they have significant...
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 13 hours agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
Merck & Co Inc (MRK) Sits And Waits For Direction At $131.30 Price – Stocks Register
Stocks Register· 1 day agoMerck & Co Inc (NYSE:MRK) at last check was buoying at $131.30 on Thursday, May 23 with a rise of 0.15% from its closing price on previous day. Taking a look at stock we notice ...
MRK Stock Sees Decline of Approximately
Knox Daily· 1 day agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Merck & Co Inc shares valued at $492,135,715 ...
Merck KGaA Buys Mirus Bio for $600 Million
Market Watch· 1 day agoBy Ian Walker Germany's Merck KGaA is buying life-science company Mirus Bio for $600 million as it expands its life science business sector. The...